← Back to Search

Hemodialysis Device

A for Chronic Kidney Disease

N/A
Waitlist Available
Led By Nathan W. Levin, MD
Research Sponsored by Renal Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 weeks
Awards & highlights

Study Summary

The purpose of the study to determine whether the level of inflammation may be decreased, the lifespan of red blood cells increased and the clearance of waste products in the blood improved through the use of the Allient System as compared to conventional hemodialysis.

Eligible Conditions
  • Chronic Kidney Disease
  • Kidney Failure

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clearance of specific waste products from blood determined through subject blood and dialysate samples
Secondary outcome measures
Inflammation as determined by levels of specific inflammatory markers
Red blood cell lifespan determined through a measurement of CO in the subject's breath

Trial Design

1Treatment groups
Experimental Treatment
Group I: AExperimental Treatment1 Intervention
Subject will continue conventional hemodialysis therapy for one week ("no intervention" phase) and then swtich to the Allient system for two weeks ("active comparator" phase).

Find a Location

Who is running the clinical trial?

Renal Research InstituteLead Sponsor
34 Previous Clinical Trials
79,374 Total Patients Enrolled
Renal Solutions, Inc.Industry Sponsor
1 Previous Clinical Trials
12 Total Patients Enrolled
Nathan W. Levin, MDPrincipal InvestigatorRenal Research Institute
1 Previous Clinical Trials
30 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby May 2025